Coagulolysis: mechanism of formation and lysis of dilute whole blood clots and application of this assay into study of certain hypercoagulable states.
D000328:Adult; D000906:Antibodies; D000888:Antibodies, Anti-Idiotypic; D001772:Blood Cell Count; D001777:Blood Coagulation / Q000187:drug effects*; D001778:Blood Coagulation Disorders; D001791:Blood Platelet Disorders; D003018:Clot Retraction; D004912:Erythrocytes / Q000378:metabolism; D005170:Factor X / Q000494:pharmacology; D005260:Female; D005337:Fibrin / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism; D005341:Fibrinolysin / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008297:Male; D010958:Plasminogen / Q000378:metabolism; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011655:Pulmonary Embolism; D013268:Stimulation, Chemical; D013917:Thrombin / Q000378:metabolism / Q000494:pharmacology; D013924:Thrombophlebitis; D013927:Thrombosis
D000906:Antibodies; D000888:Antibodies, Anti-Idiotypic; D005170:Factor X; D005337:Fibrin; D005340:Fibrinogen; D010958:Plasminogen; D013917:Thrombin; D005341:Fibrinolysin